Immunocore (NASDAQ:IMCR) Research Coverage Started at Robert W. Baird
Robert W. Baird began coverage on shares of Immunocore (NASDAQ:IMCR – Free Report) in a research report released on Tuesday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $84.00 price target on the stock. A number of other research firms have also commented on IMCR. Canaccord Genuity Group began coverage on Immunocore […]
More Stories
Analog Devices, Inc. (NASDAQ:ADI) Holdings Raised by Brighton Jones LLC
Brighton Jones LLC lifted its stake in shares of Analog Devices, Inc. (NASDAQ:ADI – Free Report) by 7.0% during the...
American Tower Corporation (NYSE:AMT) Shares Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC raised its stake in American Tower Corporation (NYSE:AMT – Free Report) by 4.7% during the first...
Zoetis Inc. (NYSE:ZTS) Stake Trimmed by Trust Point Inc.
Trust Point Inc. cut its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 30.0% in the first...
Trust Point Inc. Decreases Stock Holdings in Intel Corporation (NASDAQ:INTC)
Trust Point Inc. lowered its stake in shares of Intel Corporation (NASDAQ:INTC – Free Report) by 15.3% during the 1st...
Exchange Traded Concepts LLC Trims Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Exchange Traded Concepts LLC lowered its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.7% in the first quarter,...
General Mills, Inc. (NYSE:GIS) Stock Position Cut by Cyndeo Wealth Partners LLC
Cyndeo Wealth Partners LLC lessened its stake in General Mills, Inc. (NYSE:GIS – Free Report) by 94.7% in the first...